EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial

Xinyuan Chen, Kailiang Luo, Xia Liu, Ningrong Ye, Wei Lin, Zhenyi Liu, Xiaoping Cheng, Ziqiang Huang, Yuanyuan Xiao, Huating Zeng, Yanhua Lian, Yingjuan Zhang und 14 weitere

Brain Stimulation · 2026-11 · 19 (6) · 103205

DOI: 10.1016/j.brs.2026.103205 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Brain Stimulation, 2026-11. Verfasst von Xinyuan Chen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Clinical Center of Neuroreg…. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: No disease-modifying treatments exist for the cerebellar subtype of multiple system atrophy (MSA-C). Because transcranial alternating current stimulation (tACS) has demonstrated safety and efficacy in spinocerebellar ataxia type 3, a cerebellar disorder, we tested whether tACS improves clinical outcomes in MSA-C. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of tACS in MSA-C. Participants received daily 40-min sessions of 70 Hz, 2 mA tACS or sham stimulation, 5 days/week for 2 weeks. The primary outcome was the change from baseline to 2 weeks in the Unified Multiple System Atrophy Rating Scale (UMSARS) total score. Secondary assessments included the Scale for the Assessment and Rating of Ataxia (SARA), Scales for Outcomes in Parkinson's Disease-Autonomic Dysfunction (SCOPA-AUT), MSA quality of life (MSA-QoL), gait analysis, and fMRI. RESULTS: The primary endpoint-the change from baseline in UMSARS scores-favored active stimulation: A-tACS -4.48 (4.64) versus S-tACS 0.30 (3.98), with a mean difference of -4.78 (95% CI -6.61 to -2.94), P < 0.001. No treatment-related serious adverse events were reported. Active tACS also improved SARA and gait outcomes but not SCOPA-AUT or MSA-QoL. In exploratory fMRI analyses, no between-group effects survived FDR correction at the whole-connectome edgewise or network-pair level. A subsequent post hoc seed-based screen identified comparatively extensive connectivity-change patterns for Left Frontal Control (ContB.PFClv) and Default Mode (DefaultB.PFCd) parcels; because the seed screen was not corrected across the full 400-seed search space, these findings are hypothesis-generating rather than confirmatory. CONCLUSION: Our results show that tACS produced a statistically significant clinical improvement in MSA-C and was well tolerated. The underlying mechanisms may include enhanced brain network function.

Schlagwörter

Stichwörter der Autor:innen

Functional connectivityNeurodegenerative diseasesPlasticityTranscranial alternating current stimulationmultiple system atrophy

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Clinical Center of Neuroregulation and Brain-Computer Interface, National Regional Medical Center…
  • Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
  • Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, 350005, China.
  • Department of Neurology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
  • Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
  • College of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, 350108, China.

Förderung

  • Natural Science Foundation of Fujian Province
  • Fujian Medical University

Zitieren

APA

Chen, X., Luo, K., Liu, X., Ye, N., Lin, W., Liu, Z., Cheng, X., Huang, Z., Xiao, Y., Zeng, H., Lian, Y., Zhang, Y., Li, M., Huang, S., Wang, Z., Wang, X., Zhang, L., Lin, H., Zhang, Y., …, & OSCCAR Investigators (2026). Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial. Brain Stimulation, 19(6), 103205. https://doi.org/10.1016/j.brs.2026.103205

Vancouver

Chen X, Luo K, Liu X, Ye N, Lin W, Liu Z, et al. Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial. Brain Stimulation. 2026;19(6):103205. doi:10.1016/j.brs.2026.103205

BibTeX
@article{Chen2026,
  author = {Chen, Xinyuan and Luo, Kailiang and Liu, Xia and Ye, Ningrong and Lin, Wei and Liu, Zhenyi and Cheng, Xiaoping and Huang, Ziqiang and Xiao, Yuanyuan and Zeng, Huating and Lian, Yanhua and Zhang, Yingjuan and Li, Mengcheng and Huang, Shuna and Wang, Zhaodi and Wang, Xichen and Zhang, Lin and Lin, Haohang and Zhang, Yue and Chen, Qunlin and Wang, Duolao and Ni, Jun and Wang, Ning and Fu, Ying and Gan, Shirui and OSCCAR Investigators, OSCCAR Investigators},
  title = {Transcranial alternating current stimulation for treatment of multiple system atrophy cerebellar type: A randomized controlled trial},
  journal = {Brain Stimulation},
  year = {2026},
  volume = {19},
  number = {6},
  pages = {103205},
  doi = {10.1016/j.brs.2026.103205}
}
Kostenlos starten →